OncoForma
PrivateLast Round
Grant
Mar 24, 2026
Total Funding Raised
$1.09M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
OncoForma operates in Healthcare & Life Sciences and is based in Saskatoon. Its latest recorded funding round was a Grant round in March 2026.
OncoForma is a biotechnology company that provides precision oncology diagnostic services by using patient-derived tumor organoids to test drug efficacy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoForma Comparables
Compare OncoForma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| First Ascent Biomedical | 84% | |
| SageMedic Corp. | 84% | |
| Invitrocue | 83% |
For institutional investors. Book with your work email.
OncoForma Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
OncoForma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Saskatchewan Health Research Foundation | Grant |
| Genome Canada | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 24, 2026
$1.09M grant from Genome Canada and others.
For institutional investors. Book with your work email.
OncoForma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OncoForma's valuation, stock price, and market status.
Is OncoForma a public or private company?
OncoForma is a private company.
What is the current stock price of OncoForma?
OncoForma is a private company, so its shares have no public market price. Caplight tracks OncoForma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OncoForma worth (valuation)?
Valuation information for OncoForma is not publicly available.
Can I buy OncoForma stock?
OncoForma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OncoForma's last funding round?
OncoForma's most recent funding round was Grant on March 24, 2026.
Who are the main investors in OncoForma?
Key investors in OncoForma include Saskatchewan Health Research Foundation, Genome Canada.
Will OncoForma IPO soon?
No public IPO plans have been announced for OncoForma.
How can I track OncoForma secondary market activity?
Caplight tracks bids, offers, and trades in OncoForma's shares on secondary markets.